Volume 24, Number 3—March 2018
Research
Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel
Table 1
Age distribution of case-patients with of Sp12F infection, Israel, July 2009–June 2016*
Year |
Age <5 y |
Age 5–17 y |
Age 17–64 y |
Age >65 y |
|||||||
No. cases |
Total population |
No. cases |
Total population |
No. cases |
Total population |
No. cases |
Total population |
||||
Jul 2009–Jun 2010 | 11 | 763,700 | 1 | 1,706,200 | 3 | 4,341,250 | 5 | 743,250 | |||
Jul 2010–Jun 2011 | 17 | 784,000 | 2 | 1,737,250 | 13 | 4,405,100 | 9 | 768,100 | |||
Jul 2011–Jun 2012 | 38 | 804,750 | 1 | 1,768,700 | 16 | 4,465,500 | 14 | 799,000 | |||
Jul 2012–Jun 2013 | 36 | 824,300 | 2 | 1,802,100 | 17 | 4,526,750 | 13 | 831,750 | |||
Jul 2013–Jun 2014 | 48 | 841,400 | 2 | 1,841,100 | 15 | 4,589,000 | 12 | 866,050 | |||
Jul 2014–Jun 2015 | 34 | 864,000 | 4 | 1,904,700 | 32 | 4,692,000 | 18 | 919,600 | |||
Jul 2015–Jun 2016 |
42 |
885,600 |
2 |
1,947,100 |
13 |
4,765,500 |
14 |
959,650 |
|||
Total no. cases | 226 | 14 | 109 | 85 |
*Sp12F, Streptococcus pneumoniae serotype 12F.